CME Group Research and Development Expenses 2012-2026 | CME
CME Group annual/quarterly research and development expenses history and growth rate from 2012 to 2026. Research and development expenses can be defined as an expense arising from studies and product development processes.
- CME Group research and development expenses for the quarter ending March 31, 2026 were $0M, a 0% increase year-over-year.
- CME Group research and development expenses for the twelve months ending March 31, 2026 were $0M, a 0% increase year-over-year.
- CME Group annual research and development expenses for 2025 were $0B, a 0% decline from 2024.
- CME Group annual research and development expenses for 2024 were $0B, a 0% decline from 2023.
- CME Group annual research and development expenses for 2023 were $0B, a 0% decline from 2022.
|
CME Group Annual Research and Development Expenses (Millions of US $) |
|
|---|---|
| 2025 | |
| 2024 | |
| 2023 | |
| 2022 | |
| 2021 | |
| 2020 | |
| 2019 | |
| 2018 | |
| 2017 | |
| 2016 | |
| 2015 | |
| 2014 | |
| 2013 | |
| 2012 | |
| 2011 | |
|
CME Group Quarterly Research and Development Expenses (Millions of US $) |
|
|---|---|
| 2026-03-31 | |
| 2025-12-31 | |
| 2025-09-30 | |
| 2025-06-30 | |
| 2025-03-31 | |
| 2024-12-31 | |
| 2024-09-30 | |
| 2024-06-30 | |
| 2024-03-31 | |
| 2023-12-31 | |
| 2023-09-30 | |
| 2023-06-30 | |
| 2023-03-31 | |
| 2022-12-31 | |
| 2022-09-30 | |
| 2022-06-30 | |
| 2022-03-31 | |
| 2021-12-31 | |
| 2021-09-30 | |
| 2021-06-30 | |
| 2021-03-31 | |
| 2020-12-31 | |
| 2020-09-30 | |
| 2020-06-30 | |
| 2020-03-31 | |
| 2019-12-31 | |
| 2019-09-30 | |
| 2019-06-30 | |
| 2019-03-31 | |
| 2018-12-31 | |
| 2018-09-30 | |
| 2018-06-30 | |
| 2018-03-31 | |
| 2017-12-31 | |
| 2017-09-30 | |
| 2017-06-30 | |
| 2017-03-31 | |
| 2016-12-31 | |
| 2016-09-30 | |
| 2016-06-30 | |
| 2016-03-31 | |
| 2015-12-31 | |
| 2015-09-30 | |
| 2015-06-30 | |
| 2015-03-31 | |
| 2014-12-31 | |
| 2014-09-30 | |
| 2014-06-30 | |
| 2014-03-31 | |
| 2013-12-31 | |
| 2013-09-30 | |
| 2013-06-30 | |
| 2013-03-31 | |
| 2012-12-31 | |
| 2012-09-30 | |
| 2012-06-30 | |
| 2012-03-31 | |
| 2011-12-31 | |
| 2011-09-30 | |
| 2011-06-30 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Finance | Securities Exchanges | $105.902B | $6.521B |
| CME Group is the largest futures exchange in the world in terms of trading volume as well as notional value traded. CME Group offers a broad range of products covering major asset classes, based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals. Trades are executed through CME Group's electronic trading platforms, open outcry and privately negotiated transactions. CME Group also operates one of the world's leading central counterparty clearing providers through CME Clearing and CME Clearing Europe, which offer clearing and settlement services across asset classes for exchange-traded and over-the-counter derivatives. Apart from CME and CBOT, the company operates New York Mercantile Exchange, Inc. (NYMEX) and Commodity Exchange, Inc. (COMEX), CME Clearing Europe Limited (CMECE) and CME Europe Limited (CME Europe). The company reports the results of its operations as one operating segment mainly comprised of CME, CBOT, NYMEX and COMEX. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| S&P Global (SPGI) | United States | $126.065B | 23.30 |
| Intercontinental Exchange (ICE) | United States | $90.969B | 23.11 |
| London Stock Exchange Group - (LSEGY) | United Kingdom | $61.205B | 0.00 |
| Deutsche Boerse AG (DBOEY) | Germany | $53.734B | 22.39 |
| Nasdaq (NDAQ) | United States | $47.272B | 23.90 |
| OTC Markets Group (OTCM) | United States | $0.648B | 20.93 |